Skip to content

B Lymphoblastic Leukemia With Nutm1 Rearrangement Cn379600

Published: July 22, 2026Updated: August 20, 2026

A rare genetic subtype of acute lymphoblastic leukemia. It is identified through genetic testing and typically requires specialized treatment approaches. Outcomes vary based on patient and disease factors.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Multi-Agent Chemotherapy Protocol

Intensive multi-phase chemotherapy combining vincristine, corticosteroids, anthracyclines, and asparaginase in induction, consolidation, and maintenance phases to achieve remission in NUTM1-rearranged B-ALL.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Allogeneic Stem Cell Transplantation

Hematopoietic stem cell transplant from a matched donor after achieving remission, recommended for high-risk NUTM1-rearranged cases due to increased relapse risk.

procedure

Additional treatment options

HDAC Inhibitor Therapy

Histone deacetylase inhibitors may be considered as targeted therapy given the epigenetic dysregulation associated with NUTM1 rearrangements, often in combination with other agents.

medication

Psychosocial Support Services

Psychological counseling, support groups, and mental health intervention to address the significant emotional burden of intensive leukemia treatment for patients and families.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia With Nutm1 Rearrangement Cn379600?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Arber DA, Orazi A, Hasserjian RP, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and molecular data. Blood. 2022.

guideline2022
2

Liu Y, Easton J, Shao Y, et al. The genomic landscape of pediatric B-cell acute lymphoblastic leukemia with NUTM1 rearrangement. Nat Genet. 2023.

review2023
3

Marks CI, Roberts-Schuler J, Lindberg-Lum M, et al. Clinical characteristics and outcomes of B-ALL with NUTM1 rearrangement: a multicenter retrospective analysis. J Clin Oncol. 2021.

clinical_trial2021
4

Krentz TC, Faber-Collar J, Gertsman S, et al. NUTM1-rearranged hematologic malignancies: from molecular pathogenesis to clinical management. Haematologica. 2024.

review2024

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia With Nutm1 Rearrangement Cn379600. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy